Third Party Venue: HealthTech Innovation Consortium (HTI-C)
Lead partner: Hôpital Foch
Consortium members: Hôpital Fondation Adolphe de Rothschild, Medicen Paris Region, Université Versailles Saint Quentin en Yvelines (UVSQ)
Partners: CEA, LNE, Résah, DocCity, Ville de Suresnes, CCI IdF
The HTIC supports the development of digital technologies in healthcare across all the activities of its component hospitals, starting with the "Head and Neck/neurosciences" and "Women's Health" (Femtech) specialties. It provides a comprehensive offering from ideation to commercialization, with the idea of involving end-users (doctors, caregivers, patients).

Foch Hospital
51 663
surgical procedures per year
63 522
emergency room visits
3 503
births per year
62 000
inpatient care
More than 600
beds
Over 264,000
annual consultations (excluding maternity)
Nearly 200
clinical research studies
Rothschild Foundation
15 880
day hospital stays
162
inpatient beds
Over 350,000
consultations and technical procedures per year
Over 45,000
emergency ophthalmology visits per year
More than 180
clinical research studies
The Tiers Lieu service offering
Services offered:
- Clinical and medico-economic studies;
- Real-life studies;
- Assessment of digital technologies with AI (including CE marking);
- Co-design and user-centered methodology (patients, relatives, healthcare professionals);
- Regulatory support and accompaniment for market access;
- Access to high-level testing grounds in various fields of expertise.
Expertise mobilized:
- Living Lab at Hôpital Foch ;
- Data science and health data warehouses (Hôpital Foch, HFAR) ;
- Medicoeconomic evaluation center.
Tiers Lieu projects
Project: COLPOFOCH
Supplier: École Polytechnique
Solution: Mueller polarimetric colposcope with automatic deep learning algorithms to improve detection of precancerous cervical lesions.
Need: To improve the reliability and sensitivity of cervical cancer screening, reduce diagnostic errors, and optimize patient care pathways.
Tiers-Lieu's contribution:
o Clinical and medico-economic evaluation under real-life conditions;
o Access to experimental sites (Hôpital Foch and HFAR);
o Support for regulatory certification and CE marking.